SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-031140
Filing Date
2024-03-14
Accepted
2024-03-14 07:14:43
Documents
14
Period of Report
2024-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20240314.htm   iXBRL 8-K 39507
2 EX-99.1 cgem-ex99_1.htm EX-99.1 185840
3 GRAPHIC img184014297_0.jpg GRAPHIC 60322
  Complete submission text file 0000950170-24-031140.txt   439166

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgem-20240314.xsd EX-101.SCH 25862
15 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20240314_htm.xml XML 4885
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 24747911
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)